Koyarwar Harkokin Jarabawa na Clinical Explained
A gwaje-gwaje na asibiti na arthritis na rheumatoid, ana amfani da ka'idoji don kwatanta tasirin maganin arthritis ko maganin arthritis, ko kuma gwada gwaji guda zuwa wani. Ka'idodin, wanda aka sani da ka'idojin Rheumatology na Amirka (ACR), shine ma'auni da aka yi amfani dashi a kusan dukkanin binciken da aka wallafa wanda ke duban tasirin maganin duk wani cututtuka na rheumatic .
ACR20 shine tsarin farko na sharuddan da aka kafa, daga bisani daga ACR50 da ACR70.
Amfani da Takaddun ACR
Ana amfani da ma'aunin ACR don tantancewa da kuma inganta ingantawa a cikin ƙididdigewa ko haɗin gwiwa tare tare da ingantawa a cikin uku na sigogi biyar masu zuwa:
- Maimaitawar lokaci mai maimaita: Yayi yawan ƙonawa a cikin kwakwalwanka kamar yadda ƙwayar C-reactive ko sedimentation ta ƙaddara.
- Tambaya na haƙuri: Ta yaya kake ganin ci gaba da amsawa ga magani.
- Likita likita: Abin da likitan ku ke gani a ci gaba ku da amsa ga magani.
- Sakamakon zafi: Yaya yawancin ciwon da kuke ciki a cikin gidajenku yau da kullum.
- Tambaya ta rashin lafiya / aiki: Yaya yawancin maganin arthritis ya hana ka da damar yin ayyukanka na yau da kullum.
Ana iya amfani da ma'aunin ACR don taimaka wa likitoci da ƙayyadadden ƙayyadadden cututtuka, ko da yake suna amfani dasu don gwajin gwaji.
Fahimtar abin da ACR20, ACR50, da ACR70 ke nuna a cikin gwaji na Clinical
Binciken gwaji ya nuna yawan masu halartar taron da suka sami ACR20, ACR50, da ACR70. Alal misali, idan bincike ya nuna cewa kashi 55 cikin dari na marasa lafiya sun sami ACR20, wannan shine kashi 55 cikin dari na marasa lafiya a cikin binciken da suka samu kashi 20 cikin dari na karfin raɗaɗi ko haɗin gwiwa, da kashi 20 bisa dari a cikin uku na sauran ma'auni guda biyar.
Idan jarrabawar asibitoci ta bayar da rahoton cewa kashi 40 cikin 100 na marasa lafiya sun sami ACR50, wannan yana nufin kashi 40 cikin dari na marasa lafiya a cikin binciken ya sami kashi 50 bisa dari na cigaba da ƙarancin haɗin gwiwa, da kuma kashi 50 cikin kashi uku na sauran ma'auni guda biyar. Haka kuma ya shafi ACR70, kawai tare da kashi 70 cikin dari. Don a tantance marasa lafiya ta hanyar amfani da ACR, dole ne sun kammala jarrabawar asibiti.
ACR20 An amince da FDA
Cibiyar Abinci da Drugura ta Amurka (FDA) ta bada shawarar yin amfani da ACR20 a matsayin ma'auni na zafin zabi na gwaji na kwayoyi da ake amfani dasu don magance cutar arthritis. Wannan amincewa ya haifar da yin amfani da ACR20 sosai a gwaji. Ana kiran shi kamar ACR20 ne kawai saboda yana bukatar akalla kashi 20 cikin dari na daidaitattun ka'idodi a sama.
Sources:
> Felson DT, Anderson JJ, Boers M, et al. Kwalejin Amirka na Rheumatology Tsarin Magana na Ingantaccen Ciwon Arthritis Rheumatoid. Arthritis & Rheumatism. 1995; 38: 727-735. Doi: 10.1002 / art.1780380602.
> Felson DT, LaValley MP. Aikin ACR20 da Bayyana Mahimmanci don Amsawa a Cututtuka na Rheumatic: Mafi yawa daga Mai kyau. Arthritis Research & Far . 2014; 16 (1): 101. Doi: 10.1186 / ar4428.
Cibiyar Arthritis Johns Hopkins. Bayanin Rarraba ACR: ACR Ma'anar Ingantawa a RA Trials. Medicine Johns Hopkins. An sabunta Agusta 16, 2017.
Rocha K. ACR Score: Tsarin Ritumatoid Arthritis. Rheumatoid Arthritis Support Network. Updated Maris 22, 2017.